145 related articles for article (PubMed ID: 31269269)
1. Deficient glucose uptake is linked to impaired Glut1 expression upon CD3/CD28 stimulation in memory T cells from pleural effusions secondary to lung cancer.
Prado-Garcia H; Romero-Garcia S; Castro-Flores DA; Rumbo-Nava U
Scand J Immunol; 2019 Sep; 90(3):e12802. PubMed ID: 31269269
[TBL] [Abstract][Full Text] [Related]
2. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways.
Jacobs SR; Herman CE; Maciver NJ; Wofford JA; Wieman HL; Hammen JJ; Rathmell JC
J Immunol; 2008 Apr; 180(7):4476-86. PubMed ID: 18354169
[TBL] [Abstract][Full Text] [Related]
3. A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.
Alvarez-Fernández C; Escribà-Garcia L; Vidal S; Sierra J; Briones J
J Transl Med; 2016 Jul; 14(1):214. PubMed ID: 27435312
[TBL] [Abstract][Full Text] [Related]
4. CD28 costimulation induces delta opioid receptor expression during anti-CD3 activation of T cells.
Nguyen K; Miller BC
J Immunol; 2002 May; 168(9):4440-5. PubMed ID: 11970987
[TBL] [Abstract][Full Text] [Related]
5. Activation-induced cell death of memory CD8+ T cells from pleural effusion of lung cancer patients is mediated by the type II Fas-induced apoptotic pathway.
Prado-Garcia H; Romero-Garcia S; Morales-Fuentes J; Aguilar-Cazares D; Lopez-Gonzalez JS
Cancer Immunol Immunother; 2012 Jul; 61(7):1065-80. PubMed ID: 22159518
[TBL] [Abstract][Full Text] [Related]
6. Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression.
Prado-Garcia H; Aguilar-Cazares D; Meneses-Flores M; Morales-Fuentes J; Lopez-Gonzalez JS
Cancer Immunol Immunother; 2008 Mar; 57(3):325-36. PubMed ID: 17668204
[TBL] [Abstract][Full Text] [Related]
7. Predominance of Th17 over regulatory T-cells in pleural effusions of patients with lung cancer implicates a proinflammatory profile.
Prado-Garcia H; Romero-Garcia S; Rumbo-Nava U; Lopez-Gonzalez JS
Anticancer Res; 2015 Mar; 35(3):1529-35. PubMed ID: 25750307
[TBL] [Abstract][Full Text] [Related]
8. Low oxygen tension enhances the stimulation and proliferation of human T lymphocytes in the presence of IL-2.
Carswell KS; Weiss JW; Papoutsakis ET
Cytotherapy; 2000; 2(1):25-37. PubMed ID: 12042052
[TBL] [Abstract][Full Text] [Related]
9. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
Zhang H; Snyder KM; Suhoski MM; Maus MV; Kapoor V; June CH; Mackall CL
J Immunol; 2007 Oct; 179(7):4910-8. PubMed ID: 17878391
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of phosphotyrosine signaling networks triggered by CD3 and CD28 costimulation in Jurkat cells.
Kim JE; White FM
J Immunol; 2006 Mar; 176(5):2833-43. PubMed ID: 16493040
[TBL] [Abstract][Full Text] [Related]
11. Differences in responsiveness to CD3 stimulation between naive and memory CD4+ T cells cannot be overcome by CD28 costimulation.
Kuiper H; Brouwer M; de Boer M; Parren P; van Lier RA
Eur J Immunol; 1994 Sep; 24(9):1956-60. PubMed ID: 7522154
[TBL] [Abstract][Full Text] [Related]
12. Glucose transporter 1 protein detected by enzyme-linked immunosorbent assay and immunocytochemistry: a useful diagnostic tool for malignant pleural effusions.
Liao ND; Chiang TA; Lee WY
Cancer Cytopathol; 2013 Dec; 121(12):695-702. PubMed ID: 23861325
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two commonly used methods for stimulating T cells.
Jiao J; Zhao X; Hou R; Wang Y; Chang W; Liang N; Liu Y; Xing J; Cao Y; Li X; Zhang K
Biotechnol Lett; 2019 Dec; 41(12):1361-1371. PubMed ID: 31631231
[TBL] [Abstract][Full Text] [Related]
14. Effector, memory and naïve CD8+ T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients.
Prado-Garcia H; Aguilar-Cazares D; Flores-Vergara H; Mandoki JJ; Lopez-Gonzalez JS
Lung Cancer; 2005 Mar; 47(3):361-71. PubMed ID: 15713519
[TBL] [Abstract][Full Text] [Related]
15. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation.
Carabasi MH; DiSanto JP; Yang SY; Dupont B
Tissue Antigens; 1991 Jan; 37(1):26-32. PubMed ID: 1676547
[TBL] [Abstract][Full Text] [Related]
16. Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation.
Kusmartsev SA; Li Y; Chen SH
J Immunol; 2000 Jul; 165(2):779-85. PubMed ID: 10878351
[TBL] [Abstract][Full Text] [Related]
17. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
18. CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells.
Johnson-Léger C; Christensen J; Klaus GG
Int Immunol; 1998 Aug; 10(8):1083-91. PubMed ID: 9723694
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.
Hombach A; Wieczarkowiecz A; Marquardt T; Heuser C; Usai L; Pohl C; Seliger B; Abken H
J Immunol; 2001 Dec; 167(11):6123-31. PubMed ID: 11714771
[TBL] [Abstract][Full Text] [Related]
20. Tumor expression of 4-1BB ligand sustains tumor lytic T cells.
Zhang H; Merchant MS; Chua KS; Khanna C; Helman LJ; Telford B; Ward Y; Summers J; Toretsky J; Thomas EK; June CH; Mackall CL
Cancer Biol Ther; 2003; 2(5):579-86. PubMed ID: 14614331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
